Rare diseases
Investigational molecules
Locations
290 conditions with trials, the busiest first
1 641 trials across Europe, recruiting first
Study on Vimseltinib for Patients with Tenosynovial Giant Cell Tumor
FranceStudy on the Safety and Effects of Dasatinib for Reducing Inflammation in People with HIV on Antiretroviral Therapy
SpainStudy on the Safety of Doravirine and Islatravir for HIV Patients Who Previously Participated in Doravirine/Islatravir Trials
FranceLong-Term Study of Ustekinumab for Patients with Crohn's Disease Who Previously Lost Response to Treatment
BelgiumStudy of Batoclimab for Treating Patients with Active Thyroid Eye Disease
BelgiumStudy on Ravulizumab for Adults with Immunoglobulin A Nephropathy (IgAN) to Preserve Kidney Function
AustriaStudy on the Effectiveness and Tolerability of Oral vs. Subcutaneous Methotrexate for Patients with Early Rheumatoid Arthritis
SwedenStudy Comparing Risankizumab and Deucravacitinib for Adults with Moderate Plaque Psoriasis Eligible for Systemic Therapy
BelgiumStudy on the Safety and Tolerability of Teprotumumab for Patients with Thyroid Eye Disease
FranceStudy on Allogenic Stem Cells and Amniotic Membrane for Patients with Advanced Corneal Ulcers Unresponsive to Standard Treatment
SpainStudy on the Effects of ARO-RAGE (ADS-015) for Patients with Inflammatory Lung Disease
PolandStudy on Long-Term Safety and Efficacy of Ocrelizumab for Patients with Multiple Sclerosis
AustriaThe therapies tested most often in Immune system disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
